CHEK2 and breast cancer: On the other hand, the data underscore that further investigations for CHEK2 1100delC-associated BC in greater sample sizes, and other specific CHEK2 mutations, being more prevalent in other countries, are warranted aiming at increased knowledge and further personalized therapy.